Hendrik Schulze-Koops Selected Research

Cough

9/2019

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hendrik Schulze-Koops Research Topics

Disease

38	Rheumatoid Arthritis 04/2022 - 01/2002
13	Rheumatic Diseases (Rheumatism) 09/2021 - 01/2012
10	COVID-19 01/2022 - 01/2020
9	Infections 01/2022 - 05/2011
8	Inflammation (Inflammations) 01/2021 - 09/2002
8	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 09/2002
5	Psoriatic Arthritis 12/2020 - 12/2006
5	Arthritis (Polyarthritis) 11/2019 - 10/2010
4	Neoplasms (Cancer) 11/2021 - 02/2008
4	Necrosis 01/2021 - 08/2014
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2020 - 01/2019
4	Disease Progression 09/2019 - 04/2014
2	Adult-Onset Still's Disease 01/2020 - 09/2012
2	Giant Cell Arteritis (Horton Disease) 01/2019 - 01/2017
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2015 - 11/2012
2	Vasculitis (Vasculitides) 11/2012 - 05/2011
2	Pemphigus (Pemphigus Vulgaris) 10/2012 - 05/2011
1	Gastroenteritis 01/2022
1	Appendicitis 01/2022
1	Abscess 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Sarcoidosis (Schaumann Disease) 11/2021
1	Kidney Diseases (Kidney Disease) 09/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Myalgia 09/2019
1	Cough 09/2019
1	Headache (Headaches) 09/2019
1	Heartburn (Pyrosis) 09/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2018
1	Fever (Fevers) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Synovitis 01/2018
1	Axial Spondyloarthritis 11/2017
1	Fatigue 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2017
1	Sialadenitis 12/2015

Drug/Important Bio-Agent (IBA)

14	Antirheumatic Agents (DMARD)IBA 01/2021 - 10/2010
13	Biological ProductsIBA 01/2021 - 10/2002
12	Rituximab (Mabthera)FDA Link 10/2021 - 11/2005
11	GlucocorticoidsIBA 01/2022 - 10/2010
7	tofacitinibIBA 04/2022 - 08/2012
6	Methotrexate (Mexate)FDA LinkGeneric 10/2021 - 01/2018
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 02/2005
5	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2017
5	Janus Kinase InhibitorsIBA 01/2022 - 08/2012
5	Biosimilar PharmaceuticalsIBA 01/2019 - 01/2017
5	Monoclonal AntibodiesIBA 11/2017 - 11/2005
4	Adalimumab (Humira)FDA Link 12/2020 - 01/2012
4	CytokinesIBA 09/2020 - 01/2002
3	Immunologic Factors (Immunomodulators)IBA 01/2022 - 08/2012
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
3	Etanercept (Enbrel)FDA Link 01/2019 - 01/2012
3	golimumab FDA Link 01/2016 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
2	baricitinibIBA 01/2022 - 07/2019
2	VaccinesIBA 11/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2021 - 05/2019
2	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 11/2017
2	ixekizumabIBA 12/2020 - 10/2020
2	InterleukinsIBA 01/2020 - 02/2014
2	GP2015IBA 01/2019 - 01/2018
2	AntibodiesIBA 01/2019 - 06/2008
2	C-Reactive ProteinIBA 01/2018 - 07/2012
2	Infliximab (Remicade)FDA Link 01/2018 - 01/2012
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2017
2	amsonic acid (DAS)IBA 01/2017 - 04/2014
2	secukinumabIBA 01/2016 - 02/2014
2	Antiviral Agents (Antivirals)IBA 09/2013 - 11/2010
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2006 - 05/2006
1	ianalumabIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	IpilimumabIBA 11/2021
1	ORALIT (ORS)IBA 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	canakinumab FDA Link 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	NivolumabIBA 11/2019
1	EnzymesIBA 09/2019
1	Genetic Markers (Genetic Marker)IBA 09/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	ametantrone (HAQ)IBA 01/2017
1	interleukin-6 receptor alphaIBA 01/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 12/2015
1	MicroRNAs (MicroRNA)IBA 06/2015

Therapy/Procedure

19	Therapeutics 01/2022 - 02/2008
4	Immunotherapy 11/2021 - 11/2005
2	Immunomodulation 01/2022 - 01/2021